Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-15T16:39:54.505Z Has data issue: false hasContentIssue false
  • English
  • Français

On the Discounting of Gains in Life Expectancy: Reply to Johannesson and Levin

Published online by Cambridge University Press:  10 March 2009

Eddy van Doorslaer  and
Léon Martens
Eddy van Doorslaer
Affiliation:
Institute for Medical Technology Assessment, Erasmus University, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands
Léon Martens
Affiliation:
Abt Associates Inc., Cambridge, MA, U.S.A.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editors
Information
International Journal of Technology Assessment in Health Care , Volume 7 , Issue 4 , Fall 1991 , pp. 653 - 656
Copyright
Copyright © Cambridge University Press 1991

References

1.Abel Olsen, J. Is the time preference rate for health different? Paper presented to the Second World Conference on Health Economics, University of Zurich, Switzerland, 09 1990, 103–04.Google Scholar
2.Fuchs, V. R., & Zeckhauser, R.Valuing health—A “priceless”commodity. American Economic Review, 1987, 77, 263–68.Google ScholarPubMed
3.Johannesson, M. A note on the discounting of gained life-years in cost-effectiveness analysis. International Journal of Technology Assessment in Health Care, in press.Google Scholar
4.Johannesson, M., & Levin, L. A. Comment on “Dealing with discounting” [Letter to the Editors]. International Journal of Technology Assessment in Health Care, 1991, 7, 651–53.CrossRefGoogle ScholarPubMed
5.Lipscomb, J.Time preference for health in cost-effectiveness analysis. Medical Care, 27, 1989, S233–53.CrossRefGoogle ScholarPubMed
6.Martens, L., & Van Doorslaer, E.Dealing with discounting: An application to the costeffectiveness of intracoronary thrombolysis with streptokinase. International Journal of Technology Assessment in Health Care, 1990, 6, 139–45.CrossRefGoogle Scholar
7.Mehrez, A., & Gafni, A.Quality-adjusted life years, utility theory and healthy-years equivalents. Medical Decision Making, 1989, 9, 142–49.CrossRefGoogle ScholarPubMed
8.Rosen, S.The value of changes in life expectancy. Journal of Risk and Uncertainty, 1988, 1, 285–304.CrossRefGoogle Scholar
9.Weinstein, M. C., & Stason, W. B.Foundation of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977, 296, 716–21.CrossRefGoogle ScholarPubMed